ERNY-ALBRECHT, K.; ERDMANN, E. Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Medical Weekly, [S. l.], v. 139, n. 1112, p. 173–173, 2009. DOI: 10.4414/smw.2009.12381. Disponível em: https://smw.ch/index.php/smw/article/view/956. Acesso em: 22 nov. 2024.